Paul Saladino· MD
well this is really what we see with heart disease and with cancer and with type 2 diabetes and metabolic syndrome and obesity and we can go through those if you want to because i've investigated the history of those
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
well this is really what we see with heart disease and with cancer and with type 2 diabetes and metabolic syndrome and obesity and we can go through those if you want to because i've investigated the history of those
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
you have to say why what changed and um you know it's so so the parallels they're almost identical with uh macular degeneration you see the same thing an incredible rarity of this disorder in in the 19th century same thing with type 2 diabetes and obesity and we can go through some of those numbers if you want to and even cancer so let me just say this real quick